A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.

A follow-up study was performed to analyze the effects of hepatitis C virus (HCV) infection on morbidity and mortality in the adult population from a village in Japan found to have endemic levels of both HCV and human T lymphotropic virus type I (HTLV-I). By use of the Cox proportional hazards model, rate ratios (RRs) and 95% confidence intervals (CIs) were estimated. Strong, significant effects of seropositivity for antibodies to HCV on self-reported incident liver disease (RR, 3.5; 95% CI, 1.9-6.4) and on death due to liver cancer (RR, 8.2; 95% CI, 1.6-41.4) were observed. Dual infection with HCV and HTLV-I seemed to have a synergistic effect on incident liver disease (RR, 5.9) as well as on death from liver cancer (RR, 21.9). HCV infection also was positively, although not significantly, associated with reported incident diabetes. Our findings suggest that coinfection with HTLV-I may affect the course of HCV-associated disease.

[1]  M. Rugge,et al.  Human immunodeficiency virus infection and hepatitis C pathology. , 2008, Liver.

[2]  L. Palomera,et al.  [Hepatitis C virus infection in patients with non Hodgkin's lymphoma]. , 2001, Medicina clinica.

[3]  T. Sodeyama,et al.  [Global epidemiology of hepatocellular carcinoma]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[4]  D. Amarapurkar.  Natural history of hepatitis C virus infection , 2000, Journal of gastroenterology and hepatology.

[5]  L. Seeff,et al.  Natural history of hepatitis C , 1997, Hepatology.

[6]  N. Turkçapar,et al.  Association of diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[7]  T. Shima,et al.  Suppression of skin reactivity to purified protein derivative by hepatitis C virus among HTLV-I carriers in Japan. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[8]  J. Rakela,et al.  Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative‐strand viral rna in various tissues , 1998, Hepatology.

[9]  A. el-Zayadi,et al.  Association of chronic hepatitis C infection and diabetes mellitus. , 1998, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[10]  J. Goudsmit,et al.  Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. , 1998, Virology.

[11]  R. Purcell,et al.  The hepatitis C virus: Overview , 1997, Hepatology.

[12]  J. Hoofnagle,et al.  Hepatitis C: The clinical spectrum of disease , 1997, Hepatology.

[13]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[14]  T. Sauerbruch,et al.  Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. , 1996, The American journal of gastroenterology.

[15]  R. Kaiser,et al.  T‐ and B‐cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti‐ hepatitis C virus—positive blood donors without viremi , 1996 .

[16]  H. Tsubouchi,et al.  HCV infection and liver cancer mortality in a Japanese population with HTLV‐I , 1996, International journal of cancer.

[17]  A. Arnaiz-Villena,et al.  Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection , 1995, The Lancet.

[18]  V. Soriano,et al.  Impact of Immunosuppression Caused by HIV Infection on the Replication of Hepatitis C Virus , 1995, Vox sanguinis.

[19]  H. Alter.  To C or not to C: these are the questions. , 1995, Blood.

[20]  W. Balistreri,et al.  The hepatitis C virus: identification, epidemiology, and clinical controversies. , 1995, Journal of pediatric gastroenterology and nutrition.

[21]  S. O’Rahilly,et al.  High Prevalence of Hepatitis C Infection in Afro‐Caribbean Patients with Type 2 Diabetes and Abnormal Liver Function Tests , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[22]  P. Pontisso,et al.  HCV-associated liver cancer without cirrhosis , 1995, The Lancet.

[23]  K. Hayashi,et al.  Increased Prevalence of HTLV‐I Infection in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus , 1995, Japanese journal of cancer research : Gann.

[24]  Christine A. Lee,et al.  HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients , 1994, British journal of haematology.

[25]  J. Goedert,et al.  Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. , 1994, Blood.

[26]  J. Zeldis,et al.  Hepatitis C virus pathogenicity: the corner pieces of the jigsaw puzzle are found. , 1994, Gastroenterology.

[27]  N. Mueller,et al.  Decreased reactivity to PPD among htlv‐i carriers in relation to virus and hematologic status , 1994, International journal of cancer.

[28]  K. Yamaguchi,et al.  Human T-lymphotropic virus type I in Japan , 1994, The Lancet.

[29]  R. Rodby,et al.  Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. , 1993, Journal of the American Society of Nephrology : JASN.

[30]  M. Manns,et al.  Hepatitis C virus‐related autoimmunity in patients with porphyria cutanea tarda , 1993, European journal of clinical investigation.

[31]  B. Walker,et al.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV , 1993, Journal of virology.

[32]  N. Mueller,et al.  Analysis of anti‐tax antibody of HTLV‐I carriers in an endemic area in Japan , 1993, International journal of cancer.

[33]  P. Bouffard,et al.  Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. , 1992, The Journal of infectious diseases.

[34]  S Lemeshow,et al.  Confidence interval estimation of interaction. , 1992, Epidemiology.

[35]  E. Tabor.  Hepatitis C virus and hepatocellular carcinoma. , 1992, AIDS research and human retroviruses.

[36]  P. Cacoub,et al.  Polyarteritis Nodosa and Hepatitis C Virus Infection , 1992, Annals of Internal Medicine.

[37]  D. Pateron,et al.  Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease , 1992, The Lancet.

[38]  M. Tomonaga,et al.  Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia. , 1991, Japanese journal of medicine.

[39]  R. Purcell,et al.  Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.

[40]  M. Essex,et al.  Suppression of tuberculin skin reaction in healthy HTLV‐I carriers from Japan , 1988, International journal of cancer.

[41]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[42]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[43]  K. Yamaguchi,et al.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[44]  McCollum Rw.  The natural history of hepatitis. , 1969 .

[45]  P. Marcellin,et al.  Hepatitis C: the clinical spectrum of the disease. , 1999, Journal of hepatology.

[46]  M. Leal,et al.  Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. , 1997, Journal of hepatology.

[47]  M. Colombo,et al.  Hepatitis C Virus and Hepatocellular Carcinoma , 1999, Bailliere's best practice & research. Clinical gastroenterology.

[48]  T. Sauerbruch,et al.  Immune responses in hepatitis C virus infection. , 1996, Journal of hepatology.

[49]  M. Luppi,et al.  The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview. , 1996, Haematologica.

[50]  J. Pawlotsky,et al.  Lichen planus and hepatitis C virus--related chronic active hepatitis. , 1994, Archives of dermatology.

[51]  C. Palmer,et al.  Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. , 1994, Journal of hepatology.

[52]  S. Muñoz Fernández,et al.  [Mixed cryoglobulinemia and hepatitis C virus]. , 1993, Medicina clinica.

[53]  D. Roccatello,et al.  Hepatitis C virus infection and membranous glomerulonephritis. , 1991, Nephron.

[54]  N. Mueller,et al.  Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-I carriers. , 1990, Journal of acquired immune deficiency syndromes.

[55]  L. Stanberry,et al.  Preface to the fifth edition , 2014 .

[56]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.

[57]  R. W. Mccollum.  The natural history of hepatitis. , 1969, Bulletin of the New York Academy of Medicine.